IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $331,000 | -63.9% | 29,996 | -45.5% | 0.01% | -52.4% |
| Q1 2022 | $916,000 | -31.3% | 55,000 | -21.3% | 0.02% | -30.0% |
| Q4 2021 | $1,334,000 | -27.9% | 69,861 | -6.9% | 0.03% | -25.0% |
| Q3 2021 | $1,850,000 | +7.8% | 75,000 | +13.7% | 0.04% | +5.3% |
| Q2 2021 | $1,716,000 | +74.6% | 65,935 | +112.3% | 0.04% | +72.7% |
| Q1 2021 | $983,000 | +10.8% | 31,061 | +62.4% | 0.02% | +29.4% |
| Q4 2020 | $887,000 | -33.6% | 19,125 | -52.8% | 0.02% | -52.8% |
| Q3 2020 | $1,335,000 | +24.4% | 40,551 | +3.7% | 0.04% | +16.1% |
| Q2 2020 | $1,073,000 | +23.6% | 39,086 | +34.8% | 0.03% | -8.8% |
| Q1 2020 | $868,000 | +1.2% | 29,000 | -6.5% | 0.03% | +142.9% |
| Q4 2019 | $858,000 | +141.7% | 31,000 | +59.0% | 0.01% | +100.0% |
| Q3 2019 | $355,000 | – | 19,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |